Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

AQ 13

Next Previous
Drug Profile

AQ 13

Alternative Names: Aminoquinolone-13; AQ-13

Latest Information Update: 27 Jan 2016

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator National Institutes of Health (USA); Tulane University
  • Developer Immtech Pharmaceuticals
  • Class Aminoquinolines; Antimalarials
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Malaria
  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Malaria

Most Recent Events

  • 10 Feb 2006 Tulane University has granted Immtech International an exclusive license to develop, manufacture and commercialise aminoquinolones, including AQ 13, for the treatment, prophylaxis and diagnosis of infectious diseases
  • 18 Dec 2003 Data presented at the 52nd Annual Meeting of the American Society of Tropical Medicine and Hygiene (ASTMH-2003) have been added to the pharmacokinetics section ,,
  • 26 Apr 2000 Phase-I clinical trials for Malaria in USA (PO)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top